Adenosine inj 1mg
Products billed under this code include Adenosine.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Adenosine.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Adenosine | Henry Schein Inc. | 00404-9809-02 | 6 | $2.268 |
| Adenosine | Henry Schein Inc. | 00404-9993-02 | 6 | $2.268 |
| Adenosine | Northstar RxLLC | 16714-0556-01 | 60 | $22.68 |
| Adenosine | Northstar RxLLC | 16714-0997-01 | 90 | $34.02 |
| Adenosine | Sagent Pharmaceuticals | 25021-0301-67 | 60 | $22.68 |
| Adenosine | Sagent Pharmaceuticals | 25021-0301-68 | 120 | $45.36 |
| Adenosine | Sagent Pharmaceuticals | 25021-0318-02 | 60 | $22.68 |
| Adenosine | Sagent Pharmaceuticals | 25021-0318-04 | 120 | $45.36 |
| Adenosine | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1450-01 | 12 | $4.536 |
| Adenosine | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1450-03 | 120 | $45.36 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Adenosine | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1511-01 | 12 | $4.536 |
| Adenosine | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1632-01 | 6 | $2.268 |
| Adenosine | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1643-03 | 120 | $45.36 |
| Adenosine | Eugia US LLC | 55150-0192-01 | 60 | $22.68 |
| Adenosine | Eugia US LLC | 55150-0193-01 | 90 | $34.02 |
| Adenosine | FreseniUS Kabi USA, LLC | 63323-0651-02 | 60 | $22.68 |
| Adenosine | FreseniUS Kabi USA, LLC | 63323-0651-04 | 120 | $45.36 |
| Adenosine | FreseniUS Kabi USA, LLC | 63323-0651-20 | 60 | $22.68 |
| Adenosine | FreseniUS Kabi USA, LLC | 63323-0651-30 | 90 | $34.02 |
| Adenosine | FreseniUS Kabi USA, LLC | 63323-0651-89 | 60 | $22.68 |
| Adenosine | FreseniUS Kabi USA, LLC | 63323-0651-90 | 120 | $45.36 |
| Adenosine | Mylan Institutional LLC | 67457-0854-04 | 120 | $45.36 |
| Adenosine | Mylan Institutional LLC | 67457-0855-02 | 60 | $22.68 |
| Adenosine | Mylan Institutional LLC | 67457-0856-20 | 60 | $22.68 |
| Adenosine | Mylan Institutional LLC | 67457-0857-30 | 90 | $34.02 |
| Adenosine | Meitheal Pharmaceuticals Inc. | 71288-0207-21 | 600 | $226.80 |
| Adenosine | Meitheal Pharmaceuticals Inc. | 71288-0208-30 | 90 | $34.02 |
| Adenosine | Mylan Institutional LLC | 72078-0033-02 | 60 | $22.68 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.378 | −$0.016 | 1 MG | Adenosine inj 1mg | v1, posted September 17, 2026 |
| 3Q26 | $0.394 | −$0.086 | 1 MG | Adenosine inj 1mg | v1, posted September 15, 2026 |
| 2Q26 | $0.48 | −$0.049 | 1 MG | Adenosine inj 1mg | v1, posted September 15, 2026 |
| 1Q26 | $0.529 | −$0.026 | 1 MG | Adenosine inj 1mg | v1, posted September 15, 2026 |
| 4Q25 | $0.555 | +$0.099 | 1 MG | Adenosine inj 1mg | v1, posted September 8, 2026 |
| 3Q25 | $0.456 | +$0.07 | 1 MG | Adenosine inj 1mg | v1, posted March 10, 2026 |
| 2Q25 | $0.386 | +$0.07 | 1 MG | Adenosine inj 1mg | v1, posted March 10, 2026 |
| 1Q25 | $0.316 | −$0.081 | 1 MG | Adenosine inj 1mg | v1, posted December 19, 2025 |
| 4Q24 | $0.397 | −$0.026 | 1 MG | Adenosine inj 1mg | v1, posted June 11, 2025 |
| 3Q24 | $0.423 | −$0.133 | 1 MG | Adenosine inj 1mg | v1, posted June 11, 2025 |
| 2Q24 | $0.556 | −$0.045 | 1 MG | Adenosine inj 1mg | v1, posted March 11, 2025 |
| 1Q24 | $0.601 | +$0.065 | 1 MG | Adenosine inj 1mg | v1, posted December 19, 2024 |
| 4Q23 | $0.536 | −$0.004 | 1 MG | Adenosine inj 1mg | v1, posted October 10, 2024 |
| 3Q23 | $0.54 | +$0.043 | 1 MG | Adenosine inj 1mg | v1, posted June 5, 2024 |
| 2Q23 | $0.497 | −$0.018 | 1 MG | Adenosine inj 1mg | v1, posted February 23, 2024 |
| 1Q23 | $0.515 | +$0.078 | 1 MG | Adenosine inj 1mg | v1, posted December 6, 2023 |
| 4Q22 | $0.437 | −$0.03 | 1 MG | Adenosine inj 1mg | v1, posted June 22, 2023 |
| 3Q22 | $0.467 | +$0.01 | 1 MG | Adenosine inj 1mg | v1, posted June 9, 2023 |
| 2Q22 | $0.457 | −$0.066 | 1 MG | Adenosine inj 1mg | v1, posted December 14, 2022 |
| 1Q22 | $0.523 | −$0.004 | 1 MG | Adenosine inj 1mg | v1, posted June 8, 2022 |
| 4Q21 | $0.527 | −$0.07 | 1 MG | Adenosine inj 1mg | v1, posted June 2, 2022 |
| 3Q21 | $0.597 | −$0.008 | 1 MG | Adenosine inj 1mg | v1, posted June 2, 2022 |
| 2Q21 | $0.605 | +$0.052 | 1 MG | Adenosine inj 1mg | v1, posted March 1, 2022 |
| 1Q21 | $0.553 | – | 1 MG | Adenosine inj 1mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.